Editorial
Mesothelioma and mesothelin—an underused diagnostic biomarker becoming a treatment target
Abstract
The origins, development and story of mesothelin as well as a short account on other mesothelioma biomarkers is outlined in the thorough and interesting review by Creaney and Robinson (1).
